Search Within

Isabell Schulze

Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (9)
  2. Melanoma and Immunotherapeutics Service (9)
  3. Sloan Kettering Institute Postdocs (9)
  4. Solid Tumor Oncology Division (9)
  5. GSK Faculty (7)
  6. MSK Grad Students (4)

More Groups

People
  1. Taha Merghoub (9)
  2. Jedd Wolchok (6)
  3. Roberta Zappasodi (4)
  4. Sadna Budhu (3)
  5. Hyejin Choi (2)
  6. Lauren Dong (2)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (4)
  4. 2020 (1)
  5. 2019 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (3)
  2. Clinical Cancer Research (2)
  3. Cancer Research (1)
  4. Immunity (1)
  5. Nature (1)
  6. Nature Immunology (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Biomed Central Ltd (3)
  3. Nature Publishing Group (2)
  4. Cell Press (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Fundamental immune–oncogenicity trade-offs define driver mutation fitness
    Journal Article

    Hoyos, D.; Zappasodi, R.; Schulze, I.; Sethna, Z.; de Andrade, K. C.; Bajorin, D. F.; Bandlamudi, C.; Callahan, M. K.; Funt, S. A.; Hadrup, S. R.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Immunotherapy-mediated thyroid dysfunction: Genetic risk and impact on outcomes with PD-1 blockade in non-small cell lung cancer
    Journal Article

    Luo, J.; Martucci, V. L.; Quandt, Z.; Groha, S.; Murray, M. H.; Lovly, C. M.; Rizvi, H.; Egger, J. V.; Plodkowski, A. J.; Abu-Akeel, M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors
    Journal Article

    Xu, S.; Chaudhary, O.; Rodríguez-Morales, P.; Sun, X.; Chen, D.; Zappasodi, R.; Xu, Z.; Pinto, A. F. M.; Williams, A.; Schulze, I.; more...
    Immunity (2021)

    Fulltext@MSK | Save
  • CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
    Journal Article

    Wang, H.; Franco, F.; Tsui, Y. C.; Xie, X.; Trefny, M. P.; Zappasodi, R.; Mohmood, S. R.; Fernández-García, J.; Tsai, C. H.; Schulze, I.; more...
    Nature Immunology (2020)

    Fulltext@MSK | Save
  • Laminar Wash™ AUTO system: A reliable walk-away sample preparation solution for better TIL recovery without centrifugation
    Meeting Abstract

    Kim, I.; Lye, M.; Zappasodi, R.; Schulze, I.; Eberle, C.; Ke, C. Y.; Cheng, K. L.; Kon, I. C.; Pek, R.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save